For years, clinical trials have been identified by strings of letters and numbers, which is efficient for researchers, but often meaningless or even alienating for patients. As information becomes more readily available, and patients become more engaged and informed in their treatment journey, there is a shift toward making the clinical landscape increasingly patient-centric. These coded acronyms no longer meet the needs of our enlightened patient population. Today, clinical trial names are more than a checked box; they are a vital first impression, shaping how patients and caregivers perceive, understand, and interact with a study.
Why Names Matter in Clinical Trials
When patients encounter a clinical trial, whether in a registry, on social media, or through a referral, the name is often the very first touchpoint. A cold, technical acronym can feel distant and confusing, while a name that is clear, human, and intentional creates immediate trust. The difference between “ABC-123” and a thoughtfully chosen clinical trial name can determine whether a patient clicks to learn more—or moves on.
Names matter in clinical trials, but do trademarks? Read more about how Viridis Pharmaceuticals was brought to suit by third-party Hecht Pharmaceuticals for the trademark “Boswelan,” and how it affected the trial.
The Psychology of Connection
At its core, clinical trial naming is about psychology. Names have the power to create an emotional bridge between science and the people it serves. Three psychological principles stand out:
Emotional resonance: Names that suggest hope, progress, or inclusivity can reduce fear and make participation feel meaningful.
Cognitive ease: Simple, memorable names are easier for patients and caregivers to recall and share, which is critical in a process that often involves family support.
Trust and credibility: A name that aligns with the trial’s purpose or therapeutic area builds confidence in the study’s integrity.
When patients feel a connection to the name, they are more likely to engage, inquire, and ultimately participate.
Trends Driving Patient-Centric clinical trial Naming
Several forces are reshaping how sponsors approach clinical trial naming:
Patient-centricity: With recruitment and retention challenges at the forefront, patient-friendly names can improve engagement.
Globalization: Trials that run across borders require names that translate well and avoid cultural pitfalls.
Digital-first recruitment: In an era of hashtags, social campaigns, and online registries, names must be discoverable, shareable, and accessible.
This shift reflects the broader evolution of branding in healthcare: clarity, inclusivity, and connection are now essential.
Branding Lessons from Clinical Trial Names
A clinical trial name is in many ways, a brand in miniature. It signals values,
communicates purpose, and creates continuity from early-stage development
through to market launch. A thoughtfully developed name becomes a foundation
for storytelling—helping patients feel part of something bigger than a study
protocol. Just as a consumer brand competes for trust and attention, clinical
trial names must resonate in a crowded, skeptical landscape.
To learn more about how awareness, credibility and attracting participants play a role in
clinical trial branding, see this article Key considerations for developing strong clinical
trial branding.
Moving Beyond Acronyms
Clinical trial names are the first step in building trust with patients. By moving beyond
acronyms and embracing patient-centric, emotionally intelligent naming
strategies, sponsors can foster stronger engagement, improve recruitment, and
lay the groundwork for future brand equity.
At Brandsymbol, we believe naming is not just a creative exercise, but a strategic tool. By
blending linguistic insight, cultural sensitivity, and branding expertise, we
help organizations create trial names that connect science with the people who need it most.